These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
866 related items for PubMed ID: 18355815
1. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G. Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815 [Abstract] [Full Text] [Related]
2. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS. Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515 [Abstract] [Full Text] [Related]
3. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938 [Abstract] [Full Text] [Related]
4. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May 01; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
5. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. Sagnelli E, Imparato M, Coppola N, Pisapia R, Sagnelli C, Messina V, Piai G, Stanzione M, Bruno M, Moggio G, Caprio N, Pasquale G, Del Vecchio Blanco C. J Med Virol; 2008 Sep 01; 80(9):1547-53. PubMed ID: 18649338 [Abstract] [Full Text] [Related]
6. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B]. Lee CK, Suh JH, Cho YS, Han KH, Chung JB, Chon CY, Moon YM. Taehan Kan Hakhoe Chi; 2002 Jun 01; 8(2):139-48. PubMed ID: 12499799 [Abstract] [Full Text] [Related]
7. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans. Sprengers D, van der Molen RG, Kusters JG, De Man RA, Niesters HG, Schalm SW, Janssen HL. J Hepatol; 2006 Aug 01; 45(2):182-9. PubMed ID: 16516331 [Abstract] [Full Text] [Related]
8. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators. J Med Virol; 2007 Jun 01; 79(6):694-700. PubMed ID: 17457912 [Abstract] [Full Text] [Related]
9. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin SK. J Gastroenterol Hepatol; 2009 Apr 01; 24(4):588-98. PubMed ID: 19207682 [Abstract] [Full Text] [Related]
10. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C. Gut; 2009 Jul 01; 58(7):974-82. PubMed ID: 19201769 [Abstract] [Full Text] [Related]
11. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD. Liver Transpl; 2003 Dec 01; 9(12):1253-7. PubMed ID: 14625824 [Abstract] [Full Text] [Related]
12. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC. Mikrobiyol Bul; 2007 Apr 01; 41(2):227-33. PubMed ID: 17682709 [Abstract] [Full Text] [Related]
13. Change of hepatitis B virus DNA status in anti-HBc positive liver graft. Kwon CH, Suh KS, Cho JY, Yi NJ, Jang JJ, Lee KU. Korean J Hepatol; 2006 Jun 01; 12(2):191-200. PubMed ID: 16804344 [Abstract] [Full Text] [Related]
14. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Ghisetti V, Marzano A, Zamboni F, Barbui A, Franchello A, Gaia S, Marchiaro G, Salizzoni M, Rizzetto M. Liver Transpl; 2004 Mar 01; 10(3):356-62. PubMed ID: 15004761 [Abstract] [Full Text] [Related]
15. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. J Gastroenterol Hepatol; 2010 Jan 01; 25(1):101-6. PubMed ID: 19817965 [Abstract] [Full Text] [Related]
16. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable? Ferraro D, Pizzillo P, Di Marco V, Vultaggio A, Iannitto E, Venezia G, Craxì A, Di Stefano R. Liver Int; 2009 Sep 01; 29(8):1171-7. PubMed ID: 19602139 [Abstract] [Full Text] [Related]
17. [Detection of Intrahepatic HBV DNA in HBsAg-negative liver diseases]. Kim YS, Jang JY, Eun SH, Cheon YK, Kim YS, Moon JH, Cho YD, Jin SY, Shim CS, Kim BS. Korean J Hepatol; 2006 Jun 01; 12(2):201-8. PubMed ID: 16804345 [Abstract] [Full Text] [Related]
18. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R, Santantonio T, Brancatelli S, Colucci G, Raimondo G. Hepatology; 2000 Feb 01; 31(2):507-12. PubMed ID: 10655278 [Abstract] [Full Text] [Related]
19. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M. J Viral Hepat; 2004 Jul 01; 11(4):297-301. PubMed ID: 15230851 [Abstract] [Full Text] [Related]
20. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P, Missale G, Ferrari C. Gastroenterology; 2010 Feb 01; 138(2):682-93, 693.e1-4. PubMed ID: 19800335 [Abstract] [Full Text] [Related] Page: [Next] [New Search]